Clinical Trial Update: Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing different first-line therapies for Helicobacter pylori infection, including vonoprazan-based regimens and various quadruple/dua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth quadruple therapy
• High-dose Dual Therapy
• lansoprazole-based therapy (lansoprazole)
• non-bismuth quadruple therapy
• vonoprazan-based therapy (vonoprazan)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: H. Pylori Infection | Phase 4 | Status: RECRUITING